Management spelt it out yesterday about licensing this drug to a big pharma and we know big pharma is looking at the cardiovascular indication as per CEO. Rest takes care of itself. I’m wanting update on the TBI us defence force phase 2 trial hopefully they give us some insight next week in the webinar
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $69.60M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.3¢ | 32.5¢ | $195.9K | 589.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14970 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 20100 | 1 |
View Market Depth
| Last trade - 15.29pm 25/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |